Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).

Sarah Larson, MD, Nicholas Campbell, MD, Dezheng Huo, PhD, Andrew Artz, MD, MS, Yanming Zhang, Devika Gajria, Margaret Green, Gamar Rahimova, Howard Weiner, Monica Torres, Olatoyosi Odenike, MD, Lucy A Godley, MD, PhD, Elizabeth Shima Rich, MD, PhD, Michael Thirman, MD, Richard A. Larson, MD, Wendy Stock, MD

Blood (2009) 114 (22): 1048.

https://doi.org/10.1182/blood.V114.22.1048.1048

Published: 2009

Journal Articles

Phase II Trial of Low Dose, Subcutaneous Decitabine in Myelofibrosis

Olatoyosi M Odenike, John E. Godwin, Koen Van Besien, Dezheng Huo, Dorie Sher, Patrick Burke, Scott E. Smith, Margaret Green, Julia Melnick, James L Wade, Eric P. Lester, Rebecca B. Klisovic, Maria R. Baer, Richard A Larson, Wendy Stock

Blood (2008) 112 (11): 2809.

https://doi.org/10.1182/blood.V112.11.2809.2809

Published: 2008

Journal Articles

MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility

Nathan A. Ellis, Dezheng Huo, Ozlem Yildiz, Lisa J. Worrillow, Mekhala Banerjee, Michelle M. Le Beau, Richard A. Larson, James M. Allan, Kenan Onel

Blood (2008) 112 (3): 741–749.

https://doi.org/10.1182/blood-2007-11-126508

Published: 2008

Includes: Supplemental data

Journal Articles

Genomic Rearrangements Associated with -5/del(5q) and -7/del(7q) in Myeloid Leukemias.

Thelma R. Tennant, PhD, Dezheng Huo, PhD, Elizabeth M. Davis, Richard A. Larson, MD, Michelle M. Le Beau, PhD

Blood (2007) 110 (11): 1813.

https://doi.org/10.1182/blood.V110.11.1813.1813

Published: 2007

Journal Articles

New Cytogenetic Abnormalities Are Frequent in AML and MDS Relapsing after Allogeneic Hematopoietic Cell Transplantation (HCT).

Daniel A. Pollyea, MD, Andrew S. Artz, MD, Wendy Stock, MD, Christopher Daugherty, MD, Lucy Godley, MD PhD, Olatoyosi M. Odenike, MD, Elizabeth Rich, MD PhD, Sonali M. Smith, MD, Todd Zimmerman, MD, Yanming Zhang, PhD, Dezheng Huo, PhD, Richard Larson, MD, Koen Van Besien, MD

Blood (2006) 108 (11): 3675.

https://doi.org/10.1182/blood.V108.11.3675.3675

Published: 2006

Journal Articles

The Histone Deacetylase Inhibitor (HDI) Depsipeptide Has Differential Activity in Core Binding Factor AML.

Olatoyosi M. Odenike, Serhan Alkan, Dorie Sher, John E. Godwin, Dezheng Huo, Stephen J. Brandt, Jingping Xie, Yanming Zhang, David H. Vesole, Richard A. Larson, Wendy Stock

Blood (2006) 108 (11): 1956.

https://doi.org/10.1182/blood.V108.11.1956.1956

Published: 2006

Journal Articles

Phase II Study of Decitabine in Myelofibrosis with Myeloid Metaplasia.

Olatoyosi M. Odenike, John E. Godwin, Koen van Besien, Dezheng Huo, Patrick J. Stiff, Dorie Sher, Nicole Klekowski, Margaret Green, Richard A. Larson, Wendy Stock

Blood (2006) 108 (11): 4923.

https://doi.org/10.1182/blood.V108.11.4923.4923

Published: 2006

Journal Articles

Alemtuzumab (Campath 1-H) Exposure Correlates with Risk of Chronic Graft vs Host Disease and CMV Viremia after Allogeneic Transplantation.

Justin P. Kline, MD, Rajiv Swamy, MD, Dezheng Huo, Laura Michaelis, MD, Richard A. Larson, MD, Elizabeth Rich, MD, PhD, Wendy Stock, MD, Jody Ulaszek, MS, Amittha Wickrema, PhD, Andrew Artz, MD, Maher Albitar, MD, Koen van Besien, MD

Blood (2005) 106 (11): 1818.

https://doi.org/10.1182/blood.V106.11.1818.1818

Published: 2005

Journal Articles

The Histone Deacetylase Inhibitor Depsipeptide Has Differential Activity in Specific Cytogenetic Subsets of Acute Myeloid Leukemia (AML).

Olatoyosi M. Odenike, Serhan Alkan, Dorie Sher, John E. Godwin, Dezheng Huo, Matthew Myers, Stephen J. Brandt, Yanming Zhang, David H. Vesole, Richard A. Larson, Wendy Stock

Blood (2004) 104 (11): 264.

https://doi.org/10.1182/blood.V104.11.264.264

Published: 2004

Journal Articles

Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? .

Loretta S. Li, BS, Dezheng Huo, MS, Theodore Karrison, PhD, Richard A. Larson, MD, Olufunmilayo Olopade, MD

Blood (2004) 104 (11): 2018.

https://doi.org/10.1182/blood.V104.11.2018.2018

Published: 2004

Journal Articles

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Sonali M. Smith, Michelle M. Le Beau, Dezheng Huo, Theodore Karrison, Ronald M. Sobecks, John Anastasi, James W. Vardiman, Janet D. Rowley, Richard A. Larson

Blood (2003) 102 (1): 43–52.

https://doi.org/10.1182/blood-2002-11-3343

Published: 2003

NARROW

High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).

Phase II Trial of Low Dose, Subcutaneous Decitabine in Myelofibrosis

MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility

Genomic Rearrangements Associated with -5/del(5q) and -7/del(7q) in Myeloid Leukemias.

New Cytogenetic Abnormalities Are Frequent in AML and MDS Relapsing after Allogeneic Hematopoietic Cell Transplantation (HCT).

The Histone Deacetylase Inhibitor (HDI) Depsipeptide Has Differential Activity in Core Binding Factor AML.

Phase II Study of Decitabine in Myelofibrosis with Myeloid Metaplasia.

Alemtuzumab (Campath 1-H) Exposure Correlates with Risk of Chronic Graft vs Host Disease and CMV Viremia after Allogeneic Transplantation.

The Histone Deacetylase Inhibitor Depsipeptide Has Differential Activity in Specific Cytogenetic Subsets of Acute Myeloid Leukemia (AML).

Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? .

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only